Sulfamethoxazole and Trimethoprim
Sulfamethoxazole and Trimethoprim is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Sulfamethoxazole and Trimethoprim; Generic name: SULFAMETHOXAZOLE AND TRIMETHOPRIM; Drug class: Sulfonamide Antimicrobial [EPC].
| Brand name | Sulfamethoxazole and Trimethoprim |
|---|---|
| Generic name | SULFAMETHOXAZOLE AND TRIMETHOPRIM |
| Drug class | Sulfonamide Antimicrobial [EPC] |
| Manufacturer | Cardinal Health 107, LLC |
| Used for | INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. Urinary Tract Infections For the treatment of urinary tract infections due to susceptible s |
| Dosage | DOSAGE AND ADMINISTRATION Sulfamethoxazole and trimethoprim tablets are contraindicated in pediatric patients less than 2 months of age. Urinary Tract Infections and Shigellosis in Adults and Pediatric Patients, and Acute Otitis Media in Children: Adults: The usual adult dosage in the treatment of urinary tract infections is 1 sulfamethoxazole and trimethoprim DS (double strength) tablet or 2 sulfamethoxazole and trimethoprim tablets every 12 hours for 10 to 14 days. An identical daily dosage is |
| Warnings | WARNINGS Embryofetal Toxicity Some epidemiologic studies suggest that exposure to sulfamethoxazole and trimethoprim during pregnancy may be associated with an increased risk of congenital malformations, particularly neural tube defects, cardiovascular malformations, urinary tract defects, oral clefts, and club foot. If sulfamethoxazole and trimethoprim is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be advised of the potential hazards to th |
| Active ingredient(s) | SULFAMETHOXAZOLE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08500fcb-dbec-4ac2-91c3-189d27907ec0 |